Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT02366221
Other study ID # 1999P008705
Secondary ID
Status Enrolling by invitation
Phase
First received
Last updated
Start date January 1998
Est. completion date December 2026

Study information

Verified date June 2023
Source Massachusetts General Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The specific aim of the study is to obtain long-term follow-up information on patients who have completed their standard clinical care in the Orthopaedic Hand and Upper Extremity Service. The study will help to qualify and quantify long-term recovery and outcomes from uncommon upper extremity fractures, as well as non-fracture bone and joint conditions. The hypotheses vary, but generally focus on the patterns of injury, the results of treatment and the complications encountered.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 750
Est. completion date December 2026
Est. primary completion date December 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Subjects with a history of complex arm or leg trauma who have completed their normal care in the Orthopaedic Hand and Upper Extremity Service Exclusion Criteria: - Vulnerable populations

Study Design


Related Conditions & MeSH terms


Intervention

Other:
60-minute visit to the outpatient clinic
An interview, an injury-specific physical exam and/or a set of xrays.
Phone Interview
If subject cannot return to office in Boston, researcher may conduct interview over the phone.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Massachusetts General Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Range of Motion Range of motion of joints measured in degrees with goniometer 5 years (expected average)
Secondary Upper Extremity Function PROMIS (Patient Reported Outcomes Measurement Information Systems) Upper Extremity Questionnaire 5 years (expected average)
Secondary Pain Interference PROMIS Pain Interference Questionnaire 5 years (expected average)
Secondary Depression PROMIS Depression Questionnaire 5 years (expected average)
See also
  Status Clinical Trial Phase
Completed NCT01690780 - Oral Morphine Versus Ibuprofen N/A